Author

Qijia Yu

Harvard UniversityORCID 0000-0003-0409-7316Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Qijia Yu2 papers · Broad Institute

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew J. AguirreiD· 1 shared Aparna PadhyeiD· 1 shared Clara L. PoupaultiD· 1 shared Claudia Campos· 1 shared Huan ZhangiD· 1 shared Joseph Douglas ManciasiD· 1 shared Junning WangiD· 1 shared Kristopher A. SarosiekiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew J. AguirreORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedJul 30, 2025

De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer

Huan Zhang, Naiara Santana-Codina, Qijia Yu…·Joseph Douglas Mancias

This study identifies that combining DHODH inhibition with BCL-XL targeting synergistically induces apoptosis in pancreatic cancer, offering a new combination therapy strategy.

19 citationstop 4%

humanproteomics

𝕏 PostBluesky